Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Conditions: Primary Simultaneous Kidney and Pancreas Allograft Candidates; Simultaneous Kidney and Pancreas Transplantation
Interventions: Biological: Belatacept; Drug: methylprednisolone; Biological: Anti-thymocyte Globulin (Rabbit); Drug: Tacrolimus; Drug: Mycophenolate mofetil
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Clinical Trials in Organ Transplantation
Terminated - verified December 2016
Interventions: Biological: Belatacept; Drug: methylprednisolone; Biological: Anti-thymocyte Globulin (Rabbit); Drug: Tacrolimus; Drug: Mycophenolate mofetil
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Clinical Trials in Organ Transplantation
Terminated - verified December 2016